HOME >> BIOLOGY >> NEWS
Firefly compound lights up 'protein dance' in living animals

St. Louis, July 29, 2004 -- Radiologists at Washington University School of Medicine in St. Louis have developed a first-of-its-kind noninvasive imaging technique that allows them to watch two proteins interacting in live animals.

The technique genetically fuses proteins of interest with carefully cleaved sections of luciferase, the protein fireflies use to create light. When the target proteins interact, the sections of luciferase come together and create light that can be detected outside the body by a highly sensitive camera.

"Instead of looking at a protein by itself, this technique lets us see when two proteins come together and dance," says David Piwnica-Worms, M.D., Ph.D., professor of molecular biology and pharmacology and of radiology. "Those kinds of interactions are very important for many different processes, and they're also key to developing and evaluating new drugs."

Piwnica-Worms and colleagues demonstrated the technique's feasibility on human proteins that interact in the presence of the antibiotic rapamycin. The research appears today in the online edition of the Proceedings of the National Academy of Sciences and will appear in print in the Aug. 17 issue of the journal.

According to Piwnica-Worms, understanding protein interactions has become much more important to biologists in recent years. "We've learned that the human genetic code only has a fraction of the genes we expected, and as a result it's become clear that the context of protein-to-protein interactions significantly affects what proteins can do," he explains. "That's what lets us get away with so few genes -- the same protein can do different things based on when or where it's used." Scientists have studied these interactions previously in cell cultures and in solutions obtained by carefully opening up cells. Luciferase has been used previously to identify the presence of molecules in the cell and in live animals, but this is the first time
'"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
29-Jul-2004


Page: 1 2 3

Related biology news :

1. Firefly molecule could quickly shed light on how well new drugs work
2. Firefly light illuminates course of herpes infection in mice
3. Summer Science: Firefly Babies Advertise Their Bitter Taste, UD Researchers Say
4. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
5. NJIT chemist speaks Aug. 25 about compound derived from pine tree
6. New compound could give some types of cancer the one-two punch
7. Scientists identify compounds that mimic calorie restriction
8. New compound highly efficacious at reducing human tumour growth
9. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
10. New screening method turns up potential compound for treating anthrax
11. New, non-radioactive screen for antimalarial compounds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... 2019 , ... Orbsen Therapeutics, a biotechnology company focused on ... move its base of operations from the National University of Ireland (NUI) Galway ... in Galway, Ireland. , “With four clinical trials in full swing and the ...
(Date:4/4/2019)... ... April 02, 2019 , ... Researchers from Ambry Genetics ... RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant ... poster, is one of 13 presentations at the 2019 American College of Medical ...
(Date:4/1/2019)... ... 2019 , ... uBiome announces the issue of patent number ... Patent and Trademark Office on January 1, 2019 with a priority date of ... Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and Dr. Catalina Valdivia, and ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:3/27/2019)... , ... March 26, 2019 , ... A leader in ... cell services to veterinarians across the United States and Canada since 2004. The ... and soft tissue injuries in the dog, cat, and horse. Recently, VetStem ...
(Date:3/19/2019)... ... 2019 , ... The AACR annual conference pulls together a diverse group of ... cancer research. The Visikol team will be at the show at booth #3252 and ... as their digital pathology services . “For AACR this year we are highlighting ...
(Date:3/19/2019)... and BASEL, Switzerland (PRWEB) , ... ... ... Medical Center at Tel HaShomer, the largest hospital in Israel and the ... point-of-care cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will ...
Breaking Biology Technology:
Cached News: